story of the week
Irinotecan and Temozolomide in Breast Cancer Patients With Progressing CNS Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of Irinotecan and Temozolomide in Breast Cancer Patients With Progressing Central Nervous System Disease
Breast Cancer Res Treat 2019 Jun 06;[EPub Ahead of Print], ME Melisko, M Assefa, J Hwang, A DeLuca, JW Park, HS RugoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.